12
NPS Score
VS
23andMe Claimed Company
- EMPLOYEE
PARTICIPANTS - 37
- TOTAL
RATINGS
Regeneron Pharmaceuticals
- EMPLOYEE
PARTICIPANTS - 49
- TOTAL
RATINGS
23andMe vs Regeneron Pharmaceuticals
Compare 23andMe versus Regeneron Pharmaceuticals for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 37 employees and customers of 23andMe and 49 employees and customers of Regeneron Pharmaceuticals.
23andMe
23andMe's brand is ranked #643 in the list of Global Top 1000 Brands, as rated by customers of 23andMe. Their current market cap is $2.50B.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Regeneron Pharmaceuticals. Their current valuation is $49.52B.
3.7/5
Product Quality
4/5
3.3/5
Pricing
3.6/5
3.3/5
Customer Service
3.7/5
| 49% | Promoters |
|---|---|
| 14% | Passive |
| 37% | Detractors |
45
NPS Score
| 58% | Promoters |
|---|---|
| 29% | Passive |
| 13% | Detractors |
Net Promoter Score
Winner by 33
See how 23andMe compares to its competitors
Working at 23andMe vs Working at Regeneron Pharmaceuticals
77 / 100
CEO Rating
Winner by 5%
72 / 100
CEO Rating
23andMe
23andMe doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Regeneron Pharmaceuticals
Employees at Regeneron Pharmaceuticals rate their CEO, Leonard Schleifer, 72/100. This score is 5% lower than the scores of 23andMe's CEO, Anne Wojcicki.